Cardiac Syndrome X and Endothelial Dysfunction: New Concepts in Prognosis and Treatment

American Journal of Medicine

Volumn 119, Issue 7, 2006, Pages 560-566

  Hurst, Todd ^a   Olson, Tina H ^b   Olson, Lisa E ^c   Appleton, Christopher P ^a  

^a MAYO CLINIC   (United States)

^b ARIZONA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF REDLANDS   (United States)

Author keywords

Cardiac syndrome X; Endothelial dysfunction; Microvascular angina; Microvascular ischemia

Indexed keywords

ADENOSINE; ANTIANGINA PECTORIS AGENT; ARGININE; ATENOLOL; ATORVASTATIN; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; ENALAPRIL; ESTROGEN; GLITAZONE DERIVATIVE; GLYCERYL TRINITRATE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMIPRAMINE; INSULIN SENSITIZING AGENT; METFORMIN; NIFEDIPINE; NITRATE; PRAVASTATIN; PROPRANOLOL; VERAPAMIL;

ARTICLE; CARDIAC SYNDROME X; CLINICAL EXAMINATION; CLINICAL FEATURE; CORONARY ARTERY DISEASE; DIAGNOSTIC PROCEDURE; ELECTROCARDIOGRAPHY; ENDOTHELIAL DYSFUNCTION; ESTROGEN DEFICIENCY; EXERCISE; FOLLOW UP; HUMAN; INCIDENCE; INFLAMMATION; INSULIN RESISTANCE; LABORATORY TEST; LIFESTYLE; MAINTENANCE THERAPY; MEDITERRANEAN DIET; MICROVASCULAR ISCHEMIA; NOCICEPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PATHOPHYSIOLOGY; PATIENT CARE; PRIMARY PREVENTION; PRIORITY JOURNAL; PROGNOSIS; QUALITY OF LIFE; SECONDARY PREVENTION; SMOKING CESSATION; SURVIVAL; TREATMENT PLANNING; WEIGHT REDUCTION; ISCHEMIA; MICROCIRCULATION; PAIN THRESHOLD; PATHOLOGY; PHYSIOLOGY; REVIEW; RISK ASSESSMENT; SYNDROME X; VASCULAR ENDOTHELIUM;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ENDOTHELIUM, VASCULAR; ESTROGENS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; INFLAMMATION; ISCHEMIA; LIFE STYLE; MICROCIRCULATION; MICROVASCULAR ANGINA; PAIN THRESHOLD; PROGNOSIS; RISK ASSESSMENT;

EID: 33745884994     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.07.009     Document Type: Article

References (65)

1. Kaski J.C., and Russo G. Cardiac syndrome X. an overview. Hosp Pract (Off Ed) 35 2 (2000) 75-76 79-82, 85-88 passim
2. Prina L.D., Decker W.W., Weaver A.L., et al. Outcome of patients with a final diagnosis of chest pain of undetermined origin admitted under the suspicion of acute coronary syndrome. a report from the Rochester Epidemiology Project. Ann Emerg Med 43 1 (2004) 59-67
3. Pepine C.J., Balaban R.S., Bonow R.O., et al. Women's Ischemic Syndrome Evaluation: current status and future research directions: report of the National Heart, Lung and Blood Institute workshop: October 2-4, 2002: Section 1: diagnosis of stable ischemia and ischemic heart disease. Circulation 109 6 (2004) e44-e46
4. Johnson D.B. Clinical diagnosis of angina-the WISE experience. Women and Ischemia Syndrome Evaluation. Diagnosis and Pathophysiology of Ischemic Heart Disease Workshop (2002)
5. Merz N.B., Johnson B.D., Kelsey P.S.F., et al. Diagnostic, prognostic, and cost assessment of coronary artery disease in women. Am J Manag Care 7 10 (2001) 959-965
6. Kaski J.C., and Valenzuela Garcia L.F. Therapeutic options for the management of patients with cardiac syndrome X. Eur Heart J 22 4 (2001) 283-293
7. Panting J.R., Gatehouse P.D., Yang G.Z., et al. Abnormal subendocardial perfusion in cardiac syndrome X detected by cardiovascular magnetic resonance imaging. N Engl J Med 346 (2002) 1948-1953
8. Bugiardini R., Manfrini O., Pizzi C., Fontana F., and Morgagni G. Endothelial function predicts future development of coronary artery disease. a study of women with chest pain and normal coronary angiograms. Circulation 109 (2004) 2518-2523
9. Anderson T.J., Uehata A., Gerhard M.D., et al. Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26 5 (1995) 1235-1241
10. Bonetti P.O., Pumper G.M., Higano S.T., Holmes Jr. D.R., Kuvin J.T., and Lerman A. Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 44 11 (2004) 2137-2141
11. Al Suwaidi J., Higano S.T., Holmes Jr. D.R., and Lerman A. Pathophysiology, diagnosis, and current management strategies for chest pain in patients with normal findings on angiography. Mayo Clin Proc 76 8 (2001) 813-822
12. Davignon J., and Ganz P. Role of endothelial dysfunction in atherosclerosis. Circulation 109 23 Suppl 1 (2004) III27-III32
13. Kolasinska-Kloch W., Lesniak W., Kiec-Wilk B., and Malczewska-Malec M. Biochemical parameters of endothelial dysfunction in cardiological syndrome X. Scand J Clin Lab Invest 62 1 (2002) 7-13
14. Lekakis J.P., Papamichael C.M., Vemmos C.N., Voutsas A.A., Stamatelopoulos S.F., and Moulopoulos S.D. Peripheral vascular endothelial dysfunction in patients with angina pectoris and normal coronary arteriograms. J Am Coll Cardiol 31 3 (1998) 541-546
15. Halligan S., and Lerman A. Approach to the patient with chest pain and nonobstructive coronary artery disease. Prog Cardiovasc Dis 46 5 (2004) 453-464
16. Corretti M.C., Anderson T.J., Benjamin E.J., et al. Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery. a report of the International Brachial Artery Reactivity Task Force. J Am Coll Cardiol 39 2 (2002) 257-265
17. Suwaidi J.A., Hamasaki S., Higano S.T., Nishimura R.A., Holmes Jr. D.R., and Lerman A. Long-term follow-up of patients with mild coronary artery disease and endothelial dysfunction. Circulation 101 9 (2000) 948-954
18. Targonski P.V., Bonetti P.O., Pumper G.M., Higano S.T., Holmes Jr. D.R., and Lerman A. Coronary endothelial dysfunction is associated with an increased risk of cerebrovascular events. Circulation 107 22 (2003) 2805-2809
19. Torres J.L., and Ridker P.M. Clinical use of high sensitivity C-reactive protein for the prediction of adverse cardiovascular events. Curr Opin Cardiol 18 6 (2003) 471-478
20. Lanza G.A., Sestito A., Cammarota G., et al. Assessment of systemic inflammation and infective pathogen burden in patients with cardiac syndrome X. Am J Cardiol 94 1 (2004) 40-44
21. Cosin-Sales J., Pizzi C., Brown S., and Kaski J.C. C-reactive protein, clinical presentation, and ischemic activity in patients with chest pain and normal coronary angiograms. J Am Coll Cardiol 41 9 (2003) 1468-1474
22. Hayward C.S., Kelly R.P., and Collins P. The roles of gender, the menopause and hormone replacement on cardiovascular function. Cardiovasc Res 46 1 (2000) 28-49
23. Roque M., Heras M., Roig E., et al. Short-term effects of transdermal estrogen replacement therapy on coronary vascular reactivity in postmenopausal women with angina pectoris and normal results on coronary angiograms. J Am Coll Cardiol 31 1 (1998) 139-143
24. Albertsson P.A., Emanuelsson H., and Milsom I. Beneficial effect of treatment with transdermal estradiol-17-beta on exercise-induced angina and ST segment depression in syndrome X. Int J Cardiol 54 1 (1996) 13-20
25. Kaski J.C. Overview of gender aspects of cardiac syndrome X. Cardiovasc Res 53 3 (2002) 620-626
26. Cannon III R.O., Quyyumi A.A., Schenke W.H., et al. Abnormal cardiac sensitivity in patients with chest pain and normal coronary arteries. J Am Coll Cardiol 16 6 (1990) 1359-1366
27. Shapiro L.M., Crake T., and Poole-Wilson P.A. Is altered cardiac sensation responsible for chest pain in patients with normal coronary arteries? Clinical observation during cardiac catheterisation. Br Med J (Clin Res Ed) 296 6616 (1988) 170-171
28. Chauhan A., Mullins P.A., Thuraisingham S.I., Taylor G., Petch M.C., and Schofield P.M. Abnormal cardiac pain perception in syndrome X. J Am Coll Cardiol 24 2 (1994) 329-335
29. Pasceri V., Lanza G.A., Buffon A., Montenero A.S., Crea F., and Maseri A. Role of abnormal pain sensitivity and behavioral factors in determining chest pain in syndrome X. J Am Coll Cardiol 31 1 (1998) 62-66
30. Cannon III R.O., Quyyumi A.A., Mincemoyer R., et al. Imipramine in patients with chest pain despite normal coronary angiograms. N Engl J Med 330 20 (1994) 1411-1417
31. Lanza G.A., Giordano A., Pristipino C., et al. Abnormal cardiac adrenergic nerve function in patients with syndrome X detected by [123I]metaiodobenzylguanidine myocardial scintigraphy. Circulation 96 3 (1997) 821-826
32. Rosen S.D., Paulesu E., Wise R.J., and Camici P.G. Central neural contribution to the perception of chest pain in cardiac syndrome X. Heart 87 6 (2002) 513-519
33. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina). J Am Coll Cardiol 36 3 (2000) 970-1062
34. Kaski J.C., Rosano G.M., Collins P., Nihoyannopoulos P., Maseri A., and Poole-Wilson P.A. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 25 4 (1995) 807-814
35. Cannon III R.O., Watson R.M., Rosing D.R., and Epstein S.E. Efficacy of calcium channel blocker therapy for angina pectoris resulting from small-vessel coronary artery disease and abnormal vasodilator reserve. Am J Cardiol 56 4 (1985) 242-246
36. Bugiardini R., Borghi A., Biagetti L., and Puddu P. Comparison of verapamil versus propranolol therapy in syndrome X. Am J Cardiol 63 5 (1989) 286-290
37. Fragasso G., Chierchia S.L., Pizzetti G., et al. Impaired left ventricular filling dynamics in patients with angina and angiographically normal coronary arteries. effect of beta adrenergic blockade. Heart 77 1 (1997) 32-39
38. Lanza G.A., Colonna G., Pasceri V., and Maseri A. Atenolol versus amlodipine versus isosorbide-5-mononitrate on anginal symptoms in syndrome X. Am J Cardiol 84 7 (1999) 854-856 A8
39. Gibbons R.J., Abrams J., Chatterjee K., et al. ACC/AHA 2002 guideline update for the management of patients with chronic stable angina-summary article: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. (Committee on the Management of Patients with Chronic Stable Angina). J Am Coll Cardiol 41 (2003) 159-168
40. Shepherd J., Cobbe S.M., Ford I., et al., West of Scotland Coronary Prevention Study Group. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. N Engl J Med 333 20 (1995) 1301-1307
41. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals. a randomised placebo-controlled trial. Lancet 360 9326 (2002) 7-22
42. Albert M.A., Danielson E., Rifai N., and Ridker P.M. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286 1 (2001) 64-70
43. Anderson T.J., Meredith I.T., Yeung A.C., Frei B., Selwyn A.P., and Ganz P. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion. N Engl J Med 332 8 (1995) 488-493
44. Kayikcioglu M., Payzin S., Yavuzgil O., Kultursay H., Can L.H., and Soydan I. Benefits of statin treatment in cardiac syndrome-X1. Eur Heart J 24 22 (2003) 1999-2005
45. Fabian E., Varga A., Picano E., Vajo Z., Ronaszeki A., and Csanady M. Effect of simvastatin on endothelial function in cardiac syndrome X patients. Am J Cardiol 94 5 (2004) 652-655
46. Yusuf S., Sleight P., Pogue J., Bosch J., Davies R., and Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 342 3 (2000) 145-153
47. Mancini G.B., Henry G.C., Macaya C., et al. Angiotensin-converting enzyme inhibition with quinapril improves endothelial vasomotor dysfunction in patients with coronary artery disease. The TREND (Trial on Reversing ENdothelial Dysfunction) Study. Circulation 94 3 (1996) 258-265
48. Chen J.W., Hsu N.W., Wu T.C., Lin S.J., and Chang M.S. Long-term angiotensin-converting enzyme inhibition reduces plasma asymmetric dimethylarginine and improves endothelial nitric oxide bioavailability and coronary microvascular function in patients with syndrome X. Am J Cardiol 90 9 (2002) 974-982
49. Pizzi C., Manfrini O., Fontana F., and Bugiardini R. Angiotensin-converting enzyme inhibitors and 3-hydroxy-3-methylglutaryl coenzyme A reductase in cardiac Syndrome X. role of superoxide dismutase activity. Circulation 109 1 (2004) 53-58
50. Rosano G.M., Peters N.S., Lefroy D., et al. 17-beta-estradiol therapy lessens angina in postmenopausal women with syndrome X. J Am Coll Cardiol 28 6 (1996) 1500-1505
51. Palloshi A., Fragasso G., Piatti P., et al. Effect of oral L-arginine on blood pressure and symptoms and endothelial function in patients with systemic hypertension, positive exercise tests, and normal coronary arteries. Am J Cardiol 93 7 (2004) 933-935
52. Gaibazzi N., and Ziacchi V. Reversibility of stress-echo induced ST-segment depression by long-term oral n-3 PUFA supplementation in subjects with chest pain syndrome, normal wall motion at stress-echo and normal coronary angiogram. BMC Cardiovasc Disord 4 1 (2004) 1
53. Myers J., Prakash M., Froelicher V., Do D., Partington S., and Atwood J.E. Exercise capacity and mortality among men referred for exercise testing. N Engl J Med 346 11 (2002) 793-801
54. Manson J.E., Greenland P., LaCroix A.Z., et al. Walking compared with vigorous exercise for the prevention of cardiovascular events in women. N Engl J Med 347 10 (2002) 716-725
55. Eriksson B.E., Tyni-Lenne R., Svedenhag J., et al. Physical training in Syndrome X. physical training counteracts deconditioning and pain in Syndrome X. J Am Coll Cardiol 36 5 (2000) 1619-1625
56. Raitakari O.T., Adams M.R., McCredie R.J., Griffiths K.A., and Celermajer D.S. Arterial endothelial dysfunction related to passive smoking is potentially reversible in healthy young adults. Ann Intern Med 130 7 (1999) 578-581
57. Gokce N., Vita J.A., McDonnell M., et al. Effect of medical and surgical weight loss on endothelial vasomotor function in obese patients. Am J Cardiol 95 2 (2005) 266-268
58. Knoops K.T., de Groot L.C., Kromhout D., et al. Mediterranean diet, lifestyle factors, and 10-year mortality in elderly European men and women. the HALE project. JAMA 292 12 (2004) 1433-1439
59. Opherk D., Schuler G., Wetterauer K., Manthey J., Schwarz F., and Kubler W. Four-year follow-up study in patients with angina pectoris and normal coronary arteriograms ("syndrome X"). Circulation 80 6 (1989) 1610-1616
60. Lichtlen P.R., Bargheer K., and Wenzlaff P. Long-term prognosis of patients with anginalike chest pain and normal coronary angiographic findings. J Am Coll Cardiol 25 5 (1995) 1013-1018
61. Radice M., Giudici V., and Marinelli G. Long-term follow-up in patients with positive exercise test and angiographically normal coronary arteries (syndrome X). Am J Cardiol 75 8 (1995) 620-621
62. Sun S.S., Huang J.L., Tsai S.C., Ho Y.J., and Kao C.H. The higher likelihood of developing cardiomegaly during follow-up in patients with syndrome X and abnormal thallium-201 myocardial perfusion SPECT. Int J Cardiovasc Imaging 17 4 (2001) 271-278
63. Suzuki H., Matsubara H., Koba S., Murakami M., Takeyama Y., and Katagiri T. Clinical characteristics and follow-up in patients with microvascular angina. Circ J 66 7 (2002) 691-695
64. Halcox J.P., Schenke W.H., Zalos G., et al. Prognostic value of coronary vascular endothelial dysfunction. Circulation 106 6 (2002) 653-658
65. Johnson B.D., Shaw L.J., Buchthal S.D., et al. Prognosis in women with myocardial ischemia in the absence of obstructive coronary disease. results from the National Institutes of Health-National Heart, Lung, and Blood Institute-Sponsored Women's Ischemia Syndrome Evaluation (WISE). Circulation 109 24 (2004) 2993-2999